Feb 24, 2018

Scoop: Corey Lewandowski returns to the Oval Office

Lewandowsi at Trump Tower. Photo: Drew Angerer/Getty Images

Two days before President Trump gave his unchained, campaign-style speech at CPAC, he had a secret visitor in the Oval Office.

You didn't see it on the president's schedule, and the news hasn't leaked out until now, but Trump's first campaign manager Corey Lewandowski met with the president and Chief of Staff John Kelly in the Oval Office early afternoon on Wednesday.

Lewandowski has publicly criticized Kelly over his handling of the Rob Porter crisis, and the two haven't seen eye to eye on many things.

  • Lewandowski often tells Trump that he's the best campaigner in the world and he should be out there, unscripted and off the Teleprompter, letting rip like he did on the campaign trail.
  • Kelly and others inside the White House would rather Trump focus on governing and stick to his prepared remarks. Kelly often draws a bright line between campaigning and governing, and pushes Trump to "evolve" from some of his blunter rhetoric on the campaign trail.
  • Lewandowski and others on the outside have argued the opposite: "let Trump be Trump." That approach appeals to very few people in the White House, but one of the people who likes that idea is Donald J. Trump.

Trump has told confidants he wants to spend lots of time campaigning in competitive House districts and Senate states to help Republicans keep control of Congress in 2018.

Trump loves campaigning and was back in his element at CPAC on Friday, abandoning a speech he described as "boring" to crack jokes about his bald spot, mock the "fake news" and read the inflammatory anti-immigrant poem titled "The Snake."

Trump loved it and much to the chagrin of some people inside the White House who view Lewandowski as a destructive force, Trump still talks on the phone to his former campaign manager and associates him with a time when he enjoyed campaigning.

Go deeper

Italy becomes site of largest coronavirus outbreak outside of Asia

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

The novel coronavirus has spread to more nations as South Korea and Italy step up emergency measures in their countries amid rising case numbers on Sunday.

The big picture: COVID-19 has killed at least 2,462 people and infected almost 79,000 others, mostly in mainland China. South Korea increased the infectious disease alert to red, the highest possible, as its case numbers jumped to 602 and the death toll to five. Italy's government announced emergency measures as it confirmed a spike from three to 132 cases in matter of days, making it the largest outbreak outside of Asia.

Go deeperArrowUpdated 1 hour ago - Health

Iranian state TV: Hardliners win landslide victory in low-turnout election

Photo: Iranian Supreme Leader Press Office/Handout/Anadolu Agency via Getty Images

Iranian state TV announced Sunday that hardliners won a landslide victory in the country's parliamentary elections two days ago, including all 30 seats in Tehran, AP reports.

Why it matters: Voter turnout in the election only reached 42.57%, according to Iran's interior ministry, the first time turnout dipped below 50% since the 1979 Islamic Revolution. The low turnout may signal dissatisfaction with the Iranian government and the election system.

Go deeperArrow1 hour ago - World

Coronavirus threatens shortages of about 150 drugs

A medical worker in Beijing. Photo: Greg Baker/AFP via Getty Images

About 150 prescription drugs — including antibiotics, generics and some branded drugs without alternatives — are at risk of shortage if the coronavirus outbreak in China worsens, according to two sources familiar with a list of at-risk drugs compiled by the Food and Drug Administration.

Why it matters: China is a huge supplier of the ingredients used to make drugs that are sold in the U.S. If the virus decreases China's production capability, Americans who rely on the drugs made from these ingredients could be in trouble.